Locations:
Search IconSearch

Heart Transplant: Initial Postoperative Care and Where the Field Is Heading (Podcast)

Insights from an expert cardiologist and a transplant surgeon

The number of heart transplants has increased over the past few years both nationally and at Cleveland Clinic, owing to an expanded supply of donor hearts due to growing prevalence of donation after circulatory death and improved organ preservation technology.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

That means more opportunities to offer heart transplantation to patients in need, and thus more reason for referral for transplant evaluation for potentially appropriate candidates. “Our philosophy about evaluation is ‘the sooner, the better’,” says Cleveland Clinic heart failure cardiologist Sanjeeb Bhattacharya, MD. “Even if a referring cardiologist feels like their heart failure patient is still doing OK, it’s best to have that touch point early on. Hopefully I can tell the patient, ‘You’re doing well; see your cardiologist more frequently and then I can see you maybe once a year or every other year until things get a bit worse, if they do.’ In general, earlier is very much better.”

Referral considerations are just one of the issues explored by Dr. Bhattacharya and his colleague Michael Tong, MD, Director of Cardiac Transplantation and Mechanical Circulatory Support, in a recent episode of Cleveland Clinic’s Cardiac Consult podcast. The two physicians begin by discussing best practices in patient care during the first year after transplantation and move on to advancements in transplant-related technologies, organ supply and collaborative care approaches. Along the way they address the following:

  • Tailoring immunosuppression strategies to individual patient risk
  • Post-transplant biopsy and monitoring
  • Vaccinations and infection prophylaxis before and after transplant
  • Advising patients on postoperative activity and return to work
  • Donor pool expansion and technologies for assessing donor hearts for use
  • Advances in LVAD use and transplant allocation
  • Transplant in congenital heart disease patients and other complex cases

Advertisement

Click the podcast player above to listen to the 21-minute episode now or read on for an edited excerpt. Check out more Cardiac Consult episodes at clevelandclinic.org/cardiacconsultpodcast or wherever you get your podcasts.

Excerpt from the podcast

Michael Tong, MD: Another important development is that we’re able to do transplants in more and more complex patients. Patients that we wouldn’t transplant even just 10 years ago are able to be taken on with no real problem now.

One such area that you specialize in are patients with congenital heart conditions, especially those who have reached adulthood and may have had a Fontan procedure early in life. These are patients who are now reaching their 30s and 40s and their Fontan operations are failing. We have been doing transplants in these patients more and more often now, with excellent outcomes. Talk a bit about how we can help provide care for these types of patients.

Sanjeeb Bhattacharya, MD: Yes, this is a patient population that’s increasingly coming. They're in their 20s and 30s, sometimes older, and they are starting to have issues, whether they have single-ventricle physiology and are developing signs of Fontan failure or they have a complex dual-ventricle physiology and start having worsening ventricular function or regurgitation.

Historically, these individuals would not be considered great candidates for transplant because there is a lot going on with these patients, certainly from a medical standpoint and sometimes from social standpoint and other standpoints as well. But we have a very good multidisciplinary team approach — including our surgical colleagues, pediatric surgical colleagues, congenital heart disease colleagues, pediatric cardiologists, social workers, dietitians and others — that has really helped us care for these patients in two key ways. First, by identifying these patients and seeing that we can do something for them, and second by ensuring tailored management of them in the pretransplant, transplant and post-transplant periods.

Advertisement

Related Articles

stylized illustration of the olfactory receptor

Olfactory Receptor Emerges as Therapeutic Target for Resistant Platelet Reactivity in Thrombosis

Findings promise to shape future antiplatelet drug development and treatment strategies

operating room during robotic surgery

The Right Time for Robotics in Cardiothoracic Surgery

How and why we're offering robot-assisted options for a full array of cardiac operations

illustrated blood vessel containing catheter stent with podcast overlay

Optimizing PCI Outcomes Across the Spectrum of Coronary Disease (Podcast)

Insights on common questions from referring providers

stylized heart and lungs with text overlay

Our Latest Outcomes in Thoracic Surgery, Lung Transplant, HOCM and Pericarditis

A snapshot of key stats from one of the world's busiest centers

scan of the inner organs of the human midsection

It’s Time for the EVAR Community to Retire the Term ‘Endoleak’

‘Sac flow’ is more precise and will ease unfounded patient concerns, experts argue

stylized rendering of a blood coursing through a heart valve

Master the Evolving Care of Mitral and Tricuspid Valve Disease With Case-Based CME

Join us in New York Dec. 4-5 for evidence-based instruction with real-world examples

scan showing a blockage in an artery in the brain

Dual-Neuroprotection TCAR Approach Shows Strong Safety in PERFORMANCE III Trial

First-ever transcarotid artery revascularization trial with no strokes or device-related deaths

Tricuspid valve after transcatheter replacement

Who Should Be Performing Transcatheter Tricuspid Interventions?

Consensus statement outlines the team, infrastructure and experience needed to deliver TTVI safely and effectively

Ad